Pervitin induced acute myocardial infarction

Česká verzia

Authors: K. Salomonová; A. Hachová; H. Hrabáková; P. Kropáček; L. Lisá; V. Bufka
Authors place of work: III. interní-kardiologická klinika 3. lékařské fakulty UK a FN Královské Vinohrady Praha, přednosta prof. MUDr. Petr Widimský, DrSc., FESC
Published in the journal: Vnitř Lék 2012; 58(4): 319-321
Category: Case Reports

Summary

The case demonstrates how significant the effects of addictive drugs are for human organism, which may cause serious acute changes in the function of cardiovascular system and can end in permanent heart damage.

Key words:
acute myocardial infarction – metamphetamin – coronary thrombosis

Zdroje

1. Havlíček S. Léčivé přípravky s obsahem pseudoefedrinu – surovina pro nelegální výrobu metamfetaminu. Rigorózní práce na Farmaceutické fakultě Univerzity Karlovy. Hradec Králové 2009.

2. Karch SB, Stephanes BG, Ho CH. Metamphetamine-related death in San Francisco: demographic, pathologic and toxicologic profiles. J Forensic Sci 1999; 44: 359–368.

3. Toupalík P, Vaněrková H, Klír P et al. Morfologické nálezy u chronického abusu heroinu a pervitinu. Soud Lék 2002; 47: 5–7.

4. Šubrtová L. Metamfetamin (pervitin). Bulletin Národní protidrogová centrála 1998; 3: 12–14.

5. Csémy L, Kubička L, Nociar A. Drug Scene in the Czech Republic and Slovakia during the period of Transformation. Eur Addict Res 2002; 8: 159–165.

6. Foundation for a Drug-Free World. Řekni ne drogám – řekni ano životu [on line]. 2009. Dostupný na WWW: www.drogy.cz/pervitin/kap-celosvetova-epidemie-zavislosti.html.

7. Waksman J, Taylor RN Jr, Bodor GS et al. Acute Myocardial infarction associated with amphetamine use. Mayo Clin Proc 2001; 76: 323–326.

8. Turnipseed SD, Richards JR, Kirk JD et al. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J Emerg Med 2003; 24: 369–373.

9. Darlet RW, Horowitz BZ. Cardiotoxic drugs. Emerg Med Clin North Am 1995; 13: 771–791.

10. Jacobs LJ. Reversible dilated cardiomyopathy induced by methamphetamine. Clin Cardiol 1989; 12: 725–727.

11. Islam MN, Kuroki H, Hongcheng B et al. Cardiac lesions and their reversibility after long term administration of metamphetamine. Forensic Sci Int 1995; 75: 29–43.

12. He SY, Matoba R, Fujitani N et al. Cardiac muscle lesion associated with chronic administration of methamphetamine in rats. Am J forensic Med Pathol 1996; 17: 155–162.

13. Maruta T, Nihira M, Tomita Y. Histopatological study on acute poisoning of metamphetamine, morphine or cocaine. Nihon Arukoru Yakubutsu Igakkai Zasshi 1997; 32: 122–138.

14. Wijetunga M, Seto T, Lindsay J et al. Crystal metamphetamine-aasociated cardiomyopathy: tip of the iceberg? J Toxicol Clinic Toxicol 2003; 41: 981–986.

15. Turdi S, Schamber RM, Roe ND et al. Acute methamphetamine exposure inhibits cardiac contractile function. Toxicol Lett 2009; 189: 152–158.

16. Ghuran A, Nolan J. Recreational drug misuse: issues for the cardiologist. Heart 2000; 83: 627–633.

17. Borowiak KS, Ciechanowski K, Waloszczyk P. Psilocybin mushrooms (Psilocybe semlanceata) intoxication with myocardial infarction. J Toxicol Clin Toxicol 1998; 36: 47–49.

18. Yeo KK, Wijetunga M, Ito H et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med Feb 2007; 120: 165–171.

19. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction 2009; 104: 1085–1099.

20. Karch SB. The unique histology of methamphetamine cardiomyopathy: A case report. Forensic Sci Int 2011; 212: 1–4.